Cargando…
Regional Delivery of Chimeric Antigen Receptor (CAR) T-Cells for Cancer Therapy
Chimeric Antigen Receptor (CAR) T-cells are T-cells with recombinant receptors targeted to tumor antigens. CAR-T cell therapy has emerged as a mode of immunotherapy and is now being extensively explored in hematologic cancer. In contrast, CAR-T cell use in solid tumors has been hampered by multiple...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5532628/ https://www.ncbi.nlm.nih.gov/pubmed/28718815 http://dx.doi.org/10.3390/cancers9070092 |